Chronic kidney disease trials in Bulgaria

In Bulgaria 12 Also abroad 798

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Byala, Dupnitsa, Gabrovo, Gotse Delchev, Pernik, Plovdiv, Ruse, Sandanski, Sevlievo, Sliven, Sofia, Sofiya, Varna, Veliko Tirnovo
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Gabrovo, Pazardzhik, Plovdiv, Ruse, Sofia, Sofiya, Yambol
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
Phase 1Not yet taking people in Bulgaria
A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease
Where
Sofia
Age
40 years to 80 years
People
36 worldwide
Run by
Bayer
See details and how to joinNCT07431294 · EU 2025-522335-34-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Plovdiv, Sofia, Stara Zagora
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Blagoevgrad, Nova Zagora, Pleven, Plovdiv, Sandanski, Sevlievo, Sofia, Stara Zagora, Varna
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Dobrich, Gabrovo, Lom, Montana, Plovdiv, Sliven, Smolyan, Sofia, Stara Zagora
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 2Taking people
A Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with chronic kidney disease and high blood pressure
Where
Sofia, Yambol
Age
18 years and over
People
18 worldwide
Run by
AstraZeneca AB
See details and how to join2025-522407-23-00 · EU 2025-522407-23-00
Phase 3Taking people
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Where
Blagoevgrad, Dobrich, Gabrovo, Montana, Plovdiv, Sliven, Sofia, Sofiya, Varna
Age
18 years and over
People
337 worldwide
Run by
Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Botevgrad, Byala Slatina, Pleven, Plovdiv, Sofia, Sofiya, Varna, Yambol
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Dupnitsa, Haskovo, Kyustendil, Pleven, Plovdiv, Ruse, Stara Zagora, Varna
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Where
Blagoevgrad, Dobrich, Gabrovo, Montana, Pazardzhik, Plovdiv, Rousse, Sliven, Sofia, Varna
Age
18 years and over
People
429 worldwide
Run by
Genexine, Inc.
See details and how to joinNCT06466785
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Bankya, Kozloduy, Smolyan, Sofia, Sofiya, Varna
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00